MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hep.32240

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2021

Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.

Asrani Sumeet K, Ghabril Marwan S, Kuo Alexander, Merriman Raphael B, Morgan Timothy, Parikh Neehar D, Ovchinsky Nadia, Kanwal Fasiha, Volk Michael L, Ho Chanda, Serper Marina, Mehta Shivang, Agopian Vatche, Cabrera Roniel, Chernyak Victoria, El-Serag Hashem B, Heimbach Julie, Ioannou George N, Kaplan David, Marrero Jorge, Mehta Neil, Singal Amit, Salem Riad, Taddei Tamar, Walling Anne M, Tapper Elliot B

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The burden of HCC is substantial. To address gaps in HCC care, the American Association for the Study of Liver Diseases (AASLD) Practice Metrics Committee (PMC) aimed to develop a standard set of process-based measures and patient-reported outcomes (PROs) along the HCC care continuum. We identified candidate process and outcomes measures for HCC care based on structured literature review. A 13-member panel with content expertise across the HCC care continuum evaluated candidate measures on importance and performance gap using a modified Delphi approach (two rounds of rating) to define the final set of measures. Candidate PROs based on a structured scoping review were ranked by 74 patients with HCC across 7 diverse institutions. Out of 135 measures, 29 measures made the final set. These covered surveillance (6 measures), diagnosis (6 measures), staging (2 measures), treatment (10 measures), and outcomes (5 measures). Examples included the use of ultrasound (± alpha-fetoprotein [AFP]) every 6 months, need for surveillance in high-risk populations, diagnostic testing for patients with a new AFP elevation, multidisciplinary liver tumor board (MLTB) review of Liver Imaging-Reporting and Data System 4 lesions, standard evaluation at diagnosis, treatment recommendations based on Barcelona Clinic Liver Cancer staging, MLTB discussion of treatment options, appropriate referral for evaluation of liver transplantation candidacy, and role of palliative therapy. PROs include those related to pain, anxiety, fear of treatment, and uncertainty about the best individual treatment and the future. The AASLD PMC has developed a set of explicit quality measures in HCC care to help bridge the gap between guideline recommendations and measurable processes and outcomes. Measurement and subsequent implementation of these metrics could be a central step in the improvement of patient care and outcomes in this high-risk population.

Для цитирования: Asrani Sumeet K, Ghabril Marwan S, Kuo Alexander, Merriman Raphael B, Morgan Timothy, Parikh Neehar D, Ovchinsky Nadia, Kanwal Fasiha, Volk Michael L, Ho Chanda, Serper Marina, Mehta Shivang, Agopian Vatche, Cabrera Roniel, Chernyak Victoria, El-Serag Hashem B, Heimbach Julie, Ioannou George N, Kaplan David, Marrero Jorge, Mehta Neil, Singal Amit, Salem Riad, Taddei Tamar, Walling Anne M, Tapper Elliot B. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.. Hepatology (Baltimore, Md.). 2021. DOI: 10.1002/hep.32240.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.